Valeant Pharmaceuticals Intl Inc (VRX) Sells Off Ahead of Congressional Testimony

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is trading lower, as traders brace for this afternoon's testimony before the U.S. Senate

Apr 27, 2016 at 2:20 PM
facebook X logo linkedin

Outgoing Valeant Pharmaceuticals Intl Inc (NYSE:VRX) CEO Michael Pearson, as well as activist investor and board member Bill Ackman, are both testifying before Congress this afternoon about the company's alleged price-gouging tactics. Pearson is expected to say he regrets hiking certain drug prices, calling it a "mistake." It didn't help that Wells Fargo this morning published a report saying Valeant has already raised prices on 16 products this year. 

As the anticipation builds, the stock is down 3.2% at $35.07, adding to its disastrous run on the charts. While today's intraday options activity is slower than usual, put traders in recent weeks have been predicting extended losses in the near future for VRX. 

Elsewhere, short interest has been rising on the struggling stock. Over the last two reporting periods, short interest popped by almost 90%. However, at average daily volumes, it'd take VRX short sellers less than one day to buy back their positions -- leaving little chance for a short-squeeze, if the stock ever manages to rally.

Several analysts apparently still believe in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Six brokerage firms call the stock a "strong buy," while VRX's average 12-month price target stands at $63.88 -- an 82% premium to current levels. Looking ahead, the embattled biotech has until the end of May to file its long-delayed annual financial report -- though VRX has said it'll have the report ready by this Friday. 

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI